🇺🇸 FDA
Pipeline program

mycophenolate mofetil

Roche-ST-01

Approved small_molecule completed

Quick answer

mycophenolate mofetil for IGA Nephropathy is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
United Therapeutics Europe Ltd
Indication
IGA Nephropathy
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials